Raia Drogasil
Raia Drogasil, operating under parent company RD Saúde, is Brazil's largest pharmacy chain offering prescription drugs, OTC products, digital commerce, telemedicine, and clinic management SaaS to Brazilian consumers and 20,000+ healthcare professionals.
- Company typePublic
- Founded2011
- HeadquartersSão Paulo, Brazil
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Raia Drogasil does
Raia Drogasil is Brazil's largest pharmacy chain, operating two flagship retail brands — Raia and Drogasil — across Brazil under parent company RD Saúde following the 2011 merger of the two chains. The company provides prescription medications, over-the-counter products, health and wellness goods, private-label exclusive brands, and a growing portfolio of digital health services including online commerce, telemedicine, and clinic management software. Its digital channel scaled from approximately 1% of revenue in 2018 to nearly one-third by 2024, reflecting an aggressive multi-year omnichannel transformation.
The technology stack combines an in-house digital commerce platform with acquired healthtech assets. Through wholly-owned subsidiary Amplimed, Raia Drogasil operates a SaaS clinic management and telemedicine platform serving over 20,000 health professionals connected to multiple healthcare entities. Healthbit (majority-owned) provides health data analytics for disease prevention; additional subsidiaries include a pharmacy marketplace and broader health app distribution, plus corporate venture arm RD Saúde Ventures for ongoing healthtech investment. Underlying administrative expense intensity rose from 13% to 30% of revenue (2018-2024) to fund this buildout.
Raia Drogasil generates revenue primarily through transaction-based physical pharmacy retail (approximately two-thirds of revenue), digital commerce and e-commerce including telemedicine (approaching one-third by 2024), and B2B subscription SaaS through Amplimed serving healthcare professionals. The go-to-market is hybrid: omnichannel consumer retail across Brazil with a foundational physical store base, paired with B2B SaaS distribution to clinics and physicians. Customer segments span long-tail consumer pharmacy patients and healthcare providers using Amplimed; founding family governance is credited with enabling long-term capital deployment through downturns (notably the 2015 crisis) and through the multi-year margin pressure of digital buildout.
Raia Drogasil firmographics
Firmographics- Name
- Raia Drogasil
- Legal name
- Raia Drogasil S.A.
- Website
- https://rd.com.br
- Company type
- Public
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Raia Drogasil, operating under parent company RD Saúde, is Brazil's largest pharmacy chain offering prescription drugs, OTC products, digital commerce, telemedicine, and clinic management SaaS to Brazilian consumers and 20,000+ healthcare professionals.
- Ownership category
- akta.pro rank
Raia Drogasil industry classification
Industry- Product category
- Retail Pharmacy
- NAICS
- Pharmacies and Drug Retailers (45611)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Pharmacy-Led Health & Wellness Discount Retail (CRAEAHAD)
- akta.pro secondary industries
- Health, Wellness & Pharmacy Marketplaces (CRAFABAF), Health & Pharmacy Omnichannel (CRAFAEAK), Pharmacy & Health Essentials Delivery (CRAFAFAI)
Keywords
Where Raia Drogasil is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Raia Drogasil business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmacy Retail Sales: Physical pharmacy retail operations through Raia and Drogasil pharmacy chains, representing approximately two-thirds of total revenue as digital sales approach one-third
- Digital Commerce: Online sales platform that grew from 1% of revenue in 2018 to nearly one-third of total business by 2024, including e-commerce and telemedicine services
- Healthcare SaaS Services: Subscription-based SaaS software for clinic management and telemedicine serving over 20,000 health professionals through the Amplimed acquisition
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Raia Drogasil product offering
Product offeringCore offering
Raia Drogasil S.A. operates Brazil's largest pharmacy chain network under the Raia and Drogasil retail brands, selling prescription medications, OTC pharmaceuticals, and health and wellness products through physical stores and a digital commerce platform. The company has built an integrated health ecosystem that extends into digital health services, including an online telemedicine platform, the Amplimed SaaS for clinic management and telemedicine serving over 20,000 health professionals, and Healthbit's health data analytics capabilities. The retail pharmacy business represents approximately two-thirds of total revenue, with digital sales approaching one-third of revenue by 2024.
Product overview
Raia Drogasil operates under the parent company RD Saúde as a major Brazilian pharmacy retailer with two flagship pharmacy chains (Raia and Drogasil), complemented by digital health services including an online telemedicine platform. The company has expanded through strategic acquisitions including Amplimed (clinic management SaaS and telemedicine serving 20,000+ health professionals) and Healthbit (health data analytics for disease prevention). The portfolio also includes RD Saúde Ventures for startup investments, exclusive private-label brands, and Impulso for media/partnership initiatives. The company is pursuing an aggressive digital transformation strategy, with digital sales now accounting for nearly one-third of total business.
Differentiator
Problem solved
Functional benefit
Brands
- RD Saúde Ventures: Venture arm focused on health technology investments and innovation
- Impulso
Products and services
- Raia Farmácias Retail pharmacy chain under RD Saúde offering prescription medications, OTC products, and health services to Brazilian consumers through physical stores.
- Drogasil Farmácias Retail pharmacy chain under RD Saúde providing prescription medications, OTC products, and health services to Brazilian consumers through physical stores.
- Online Telemedicine Platform (Telemedicina Online) Online telemedicine platform enabling remote healthcare consultations as part of the Raia Drogasil (RD Saúde) health services offering.
- Amplimed Clinic Management and Telemedicine SaaS SaaS software for clinic management and telemedicine that serves more than 20,000 health professionals and connects with multiple healthcare entities, operated as part of RD Saúde's health ecosystem.
- Healthbit Health Data Analytics Health data analytics offering focused on disease prevention through health data analysis, operated within the RD Saúde health ecosystem after Raia Drogasil acquired a majority stake in Healthbit.
Companies that use Raia Drogasil
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Raia Drogasil technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Raia Drogasil partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- AmplimedcoreAcquisition of healthtech startup Amplimed as part of Raia Drogasil's strategy to strengthen its health ecosystem. The deal includes Amplimed's SaaS software for clinic management and telemedicine, which serves over 20,000 health professionals and connects with multiple healthcare entities. Amplimed is described as a leader in healthcare management software.
- HealthbitcoreAcquisition of majority stake in Healthbit, a health data startup, to enhance disease prevention efforts. Healthbit provides health data analytics capabilities that complement Raia Drogasil's health ecosystem strategy.
- RD Saúde VenturescoreCorporate venture arm of Raia Drogasil focused on investing in and developing new health-related businesses and technologies. Part of the company's strategy to build a comprehensive health ecosystem.
- Commercial Partners (Parceiros Comerciais)supportingCommercial partnership program under RD Saúde targeting business partners interested in collaborating with the company's retail and health ecosystem.
- Impulso (Impulso Midia)supportingMarketing and media partnership through Impulso platform, supporting commercial partners and business development within the RD Saúde ecosystem.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Raia Drogasil competitors and assessment
Company assessmentEmerging players
- Amazon Pharmacy: Online-first pharmacy retail entrant gaining traction across multiple geographies. Comparable as a digital-pharmacy competitor that pressures incumbents' digital sales mix and last-mile economics.
Broad incumbents
- CVS Health: US pharmacy retail + health services + PBM conglomerate. Comparable on the integrated retail-pharmacy-plus-clinic-plus-health-services model RD is building, though far larger and more diversified.
- Celesio / McKesson Europe: European pharmaceutical wholesaler and pharmacy operator (Lloyds Pharmacy). Comparable as a combined pharma distribution + retail pharmacy + services business operating at continental scale.
- Walgreens Boots Alliance: Global pharmacy-led health and beauty retailer with physical stores and growing digital health services. Highly comparable on the pharmacy + health ecosystem positioning RD is pursuing in Brazil.
Direct peers
- Pague Menos: Brazilian pharmacy chain and one of RD's principal domestic competitors. Comparable in product mix (Rx, OTC, health & wellness) and in operating an omnichannel model across physical stores and digital channels.
- Shoppers Drug Mart (Loblaw Companies): Canada's largest pharmacy chain, integrated with food retail via its parent Loblaw. Comparable as a pharmacy-led retailer with loyalty program, in-store clinics, and digital health services.
- Panvel: Brazilian pharmacy retailer with both physical stores and a strong e-commerce/digital pharmacy platform. Closely comparable on omnichannel retail pharmacy, beauty/wellness assortment, and digital sales growth.
- Phoenix Group: European pharmacy retail and wholesale group operating national pharmacy chains. Comparable on scale-driven pharmacy retail leadership and on building pharmacy-plus-services ecosystems.
- DPSP (Drogarias Pacheco / São Paulo): Major Brazilian drugstore chain resulting from the merger of Drogarias Pacheco and Drogaria São Paulo. Directly competes with RD in pharmacy retail across multiple Brazilian states.
Others
- Drogaria Raia (pre-merger) / Drogasil (pre-merger): Pre-merger predecessor brands (Raia and Drogasil) that combined to form Raia Drogasil in 2011. Included as historical reference for RD's chain identity and footprint evolution rather than as a current competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Raia Drogasil social profiles
Digital presenceRaia Drogasil financial estimates
Financial estimateRevenue estimate
Valuation estimate
Raia Drogasil leadership team
Management profileNumber of profiles
Profiles2 records
Raia Drogasil subsidiaries and ownership
Company hierarchySubsidiaries3 records
Raia Drogasil funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Raia Drogasil M&A and investment
M&A and investmentM&A5 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Raia Drogasil
What does Raia Drogasil do?
Raia Drogasil S.A. operates Brazil's largest pharmacy chain network under the Raia and Drogasil retail brands, selling prescription medications, OTC pharmaceuticals, and health and wellness products through physical stores and a digital commerce platform. The company has built an integrated health ecosystem that extends into digital health services, including an online telemedicine platform, the Amplimed SaaS for clinic management and telemedicine serving over 20,000 health professionals, and Healthbit's health data analytics capabilities. The retail pharmacy business represents approximately two-thirds of total revenue, with digital sales approaching one-third of revenue by 2024.
Is Raia Drogasil a public or private company?
Raia Drogasil is a public company. It is classified as public and is currently operating.
When was Raia Drogasil founded?
Raia Drogasil was founded in 2011. It employs 5,001 to 10,000 people.
Where is Raia Drogasil based?
Raia Drogasil is headquartered in São Paulo, Brazil, in the Latin America region.
How does Raia Drogasil make money?
Three revenue lines are on record. Pharmacy Retail Sales are the primary driver. The others are digital Commerce and healthcare SaaS Services.
Who are Raia Drogasil's main competitors?
Amazon Pharmacy is listed as an emerging player. Broad incumbents are CVS Health, Celesio / McKesson Europe and Walgreens Boots Alliance. Direct peers are Pague Menos, Shoppers Drug Mart (Loblaw Companies), Panvel, Phoenix Group and DPSP (Drogarias Pacheco / São Paulo). Drogaria Raia (pre-merger) / Drogasil (pre-merger) is listed as an others.
Does Raia Drogasil have an API?
No public API is recorded for Raia Drogasil.
What industry is Raia Drogasil in?
Raia Drogasil's product category is Retail Pharmacy. Its primary akta.pro industry code is CRAEAHAD, Pharmacy-Led Health & Wellness Discount Retail, with a secondary code of CRAFABAF, Health, Wellness & Pharmacy Marketplaces. Its NAICS code is 45611 and its SIC code is 5912.